LV20.19 CAR T-cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LV20.19 CAR T-cells, covering 2026-02-23 to 2026-02-23. Get the full timeline:
Most recent: Clinical Trial Update: LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies [Phase 1]